Recent Updates
Recently added Catalysts
ACRS Positive Sentiment Score: 70/100

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

Friday, May 8, 2026 1 min read
Key Takeaway: Aclaris Therapeutics, Inc. (NASDAQ: ACRS) will participate in the 2026 Bank of America Healthcare Conference held on May 14, 2026. Dr. Hugh Davis, the President and COO, is scheduled to present at 9:35 AM PT. The event will be accessible via a live and archived webcast on the Aclaris website for at least 30 days following the conference. Aclaris focuses on developing treatments for immuno-inflammatory diseases, which are often inadequately addressed by current options.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aclaris Therapeutics is actively engaging with investors by participating in significant healthcare conferences.
  • The company's focus on developing novel product candidates for immuno-inflammatory diseases reflects its commitment to innovation in the biopharmaceutical sector.
  • The presence of Aclaris' President and COO at a prestigious event like the Bank of America Healthcare Conference indicates confidence in the company's strategic direction.

Full Press Release Details

WAYNE, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday May 14, 2026, at 9:35 AM PT, Aclaris’ President and Chief Operating Officer Dr. Hugh Davis will provide a corporate presentation during the 2026 Bank of America Healthcare Conference in Las Vegas, NV.
A live and archived webcast of this event will be accessible on the Events page of the Aclaris website, www.aclaristx.com. The webcast will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.
Aclaris Therapeutics Contact:
Senior Vice President
Corporate Communications and Investor Relations
wroberts@aclaristx.com

Frequently Asked Questions

When is Aclaris' presentation at the Bank of America Conference?

Aclaris’ presentation is on May 14, 2026, at 9:35 AM PT.

Where can I access the webcast of Aclaris' event?

The webcast will be available on Aclaris' Events page for 30 days.

What focus does Aclaris Therapeutics have?

Aclaris focuses on developing treatments for immuno-inflammatory diseases.

Who is presenting at the Bank of America Healthcare Conference?

Dr. Hugh Davis, Aclaris' President and COO, will present at the conference.

What is the mission of Aclaris Therapeutics?

The mission is to develop novel treatments for patients with unmet needs.

Tags: ACRS Viatris Investor Conferences Healthcare Aclaris Therapeutics healthcare conference immuno-inflammatory diseases biopharmaceutical
Last updated: May 8, 2026